Shanghai Pharmaceuticals Holding Co., Ltd   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Shanghai China (1994)
Status: No NME R&D (1994)

Organization Overview

First Clinical Trial
2013
NCT02201043
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Shanghai Jiaolian Medicine Research and Development Co., Ltd. | Shanghai Pharmaceuticals Holding Co., Ltd